Physician profile
Shaina Samec
NPI 1780169821
$5,992.47
in general payments reported to CMS, 2019-2025
41 companies · $962 in 2025
The $962 reported for 2025 was more than what 80% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $421 · 2022: $1,205 · 2023: $1,975 · 2024: $1,430 · 2025: $962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,367.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,494.91 | 2021-2025 | |
| Janssen Biotech, INC. | $560.15 | 2022-2025 | Stelara, Tremfya, Simponi Aria |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $454.45 | 2021-2025 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $318.54 | 2021-2025 | Entyvio, Gattex, Eohilia |
| Celgene Corporation | $316.60 | 2022-2024 | Zeposia |
| Regeneron Healthcare Solutions, INC. | $243.11 | 2023-2025 | Dupixent |
| Genzyme Corporation | $234.59 | 2023-2025 | |
| Ardelyx, INC. | $233.71 | 2023-2024 | Ibsrela |
| Gilead Sciences, INC. | $204.39 | 2021-2024 | |
| Evoke Pharma, INC. | $181.05 | 2022-2025 | Gimoti |
| Lucid Diagnostics INC. | $174.43 | 2023-2025 | |
| Ironwood Pharmaceuticals, INC | $148.66 | 2021-2023 | Linzess |
| Pfizer INC. | $140.89 | 2023-2025 | |
| Procept Biorobotics Corporation | $133.19 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $114.75 | 2023 | Zeposia |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaina Samec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.